BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers

1
Comment
Favorite

BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers

Reuters03-27

BRIEF-Hims & Hers Says <a href="https://laohu8.com/S/NVO">Novo Nordisk</a>’S FDA-Approved GLP-1S Now Available With Hims & Hers

March 26 (Reuters) - Hims & Hers Health Inc HIMS.N:

NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS & HERS
HIMS & HERS HEALTH INC - WEGOVY AVAILABLE IN MULTIPLE DOSES; 7.2 MG INJECTION COMING SOON
HIMS & HERS HEALTH INC - GLP-1 MEDICATION PRICES START AT $149 PER MONTH
HIMS & HERS HEALTH INC - INTRODUCES WEIGHT LOSS MEMBERSHIP STARTING AT $39 FIRST MONTH, $149 AFTER

Source text: ID:nBwM1yVVa

Further company coverage: HIMS.N

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2622684862?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 00:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622684862","market":"fut","top_or_hot":-1,"title":"BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hims &amp; Hers Says <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>’S FDA-Approved GLP-1S Now Available With Hims &amp; Hers</title></head><body><p><span>March 26 (Reuters)</span><span> - </span>Hims &amp; Hers Health Inc <span>HIMS.N</span>:</p><ul><li><p>NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS &amp; HERS</p></li><li><p>HIMS &amp; HERS HEALTH INC - WEGOVY AVAILABLE IN MULTIPLE DOSES; 7.2 MG INJECTION COMING SOON</p></li><li><p>HIMS &amp; HERS HEALTH INC - GLP-1 MEDICATION PRICES START AT $149 PER MONTH</p></li><li><p>HIMS &amp; HERS HEALTH INC - INTRODUCES WEIGHT LOSS MEMBERSHIP STARTING AT $39 FIRST MONTH, $149 AFTER</p></li></ul><p>Source text: <span>ID:nBwM1yVVa</span></p><p>Further company coverage: <span>HIMS.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & Hers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 00:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hims &amp; Hers Says <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>’S FDA-Approved GLP-1S Now Available With Hims &amp; Hers</title></head><body><p><span>March 26 (Reuters)</span><span> - </span>Hims &amp; Hers Health Inc <span>HIMS.N</span>:</p><ul><li><p>NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS &amp; HERS</p></li><li><p>HIMS &amp; HERS HEALTH INC - WEGOVY AVAILABLE IN MULTIPLE DOSES; 7.2 MG INJECTION COMING SOON</p></li><li><p>HIMS &amp; HERS HEALTH INC - GLP-1 MEDICATION PRICES START AT $149 PER MONTH</p></li><li><p>HIMS &amp; HERS HEALTH INC - INTRODUCES WEIGHT LOSS MEMBERSHIP STARTING AT $39 FIRST MONTH, $149 AFTER</p></li></ul><p>Source text: <span>ID:nBwM1yVVa</span></p><p>Further company coverage: <span>HIMS.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIYY","symbol_name":"YieldMax HIMS Option Income Strategy ETF","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15V:1","article_id":"2622684862","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622684862","pubTimestamp":1774541007,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & HersMarch 26 (Reuters) - Hims & Hers Health Inc HIMS.N:NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS & ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIYY":"YieldMax HIMS Option Income Strategy ETF","HIMY":"Defiance Leveraged Long + Income HIMS ETF","HIMS":"Hims & Hers Health Inc.","BK4196":"保健护理服务","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","HMYY":"GraniteShares YieldBoost HIMS ETF"},"translate_title":"简介-Hims&Hers表示诺和诺德FDA批准的GLP-1现已可与Hims&Hers一起使用","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1.95,"HIMZ":0.6,"HMYY":0.6,"HIYY":0.6,"HIMY":0.6},"content_text":"BRIEF-Hims & Hers Says Novo Nordisk’S FDA-Approved GLP-1S Now Available With Hims & HersMarch 26 (Reuters) - Hims & Hers Health Inc HIMS.N:NOVO NORDISK’S FDA-APPROVED GLP-1S NOW AVAILABLE WITH HIMS & HERSHIMS & HERS HEALTH INC - WEGOVY AVAILABLE IN MULTIPLE DOSES; 7.2 MG INJECTION COMING SOONHIMS & HERS HEALTH INC - GLP-1 MEDICATION PRICES START AT $149 PER MONTHHIMS & HERS HEALTH INC - INTRODUCES WEIGHT LOSS MEMBERSHIP STARTING AT $39 FIRST MONTH, $149 AFTERSource text: ID:nBwM1yVVaFurther company coverage: HIMS.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}